Pulmonary Devices Market, by Type (Therapeutic Devices, Consumables and Accessories, Diagnostic Devices, Monitoring Devices) and, by End User (Hospitals, Ambulatory Care, Home Care): Global Opportunity Analysis and Industry Forecast, 2023-2032

Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with respiratory tract.

Factors such as increase in prevalence of respiratory diseases, rise in geriatric population, sedentary lifestyle, high prevalence of smoking, growth in pollution levels, and urbanization drive the market growth. However, reimbursement issues and harmful effects of certain respiratory care devices on neonates restrain the market growth. Moreover, rise in need for home care therapeutic devices and healthcare growth in the developing countries increase opportunities for the market growth.

The global pulmonary devices market is segmented on the basis of type, disease, end user, and region. On the basis of type, it is segmented into therapeutic devices, consumables & accessories, diagnostic devices, and monitoring devices. By therapeutic devices, it is classified into humidifiers (heated and passover humidifiers), nebulizers, oxygen concentrators (fixed and portable oxygen concentrators), positive airway pressure (PAP) devices (continuous PAP devices, automatic PAP devices, and bi-level PAP devices), reusable resuscitators (adult resuscitators and infant/neonatal resuscitators), ventilators (adult ventilators and neonatal ventilators), inhalers (metered dose inhalers and dry powder inhalers), masks (nasal masks, full-face masks, nasal pillow masks, and oral masks), nitric oxide delivery units, and oxygen hoods. The consumables and accessories segment is sub segmented into disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas, and others. The diagnostic devices segment is sub segmented into spirometers, polysomnography devices (PSG), peak flow meters, and other diagnostic devices. The monitoring devices segment is sub segmented into pulse oximeters (pulse oximeter sensors and pulse oximeter equipment), capnographs, and gas analyzers. On the basis of disease, the market is categorized into asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, infectious diseases, and others. On the basis of end-user, it is divided into hospitals, ambulatory care, and home care. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Some of the prominent players in the global market include GlaxoSmithKline plc, 3M Company, Medtronic plc, Koninklijke Philips N.V., ResMed Inc., Masimo Corporation, Thermo Fisher Scientific, Fisher & Paykel Healthcare Limited, Becton, Dickinson and Company, and Hamilton Medical AG.

Key Benefits

• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis by product helps understand the various types of devices used for treatment of pulmonary diseases.
• Comprehensive analysis of all geographical regions is provided, which helps determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which elucidates the competitive outlook of the global market.

  Pulmonary Devices Market, by Type Report Highlights

Aspects	Details
By Type	Therapeutic Devices Humidifiers Heated Humidifiers Passover Humidifiers Oxygen Concentrators Fixed Oxygen Concentrators Portable Oxygen Concentrators Positive Airway Pressure (PAP) Devices Continuous PAP Devices Automatic PAP Devices Bi-level PAP Devices Reusable Resuscitators Adult Resuscitators Infant/Neonatal Resuscitators Ventilators Adult Ventilators Neonatal Ventilators Masks Nasal Masks Full-face Masks Nasal Pillow Masks Oral Masks Inhalers Metered Dose Inhalers Dry Powder Inhalers Nebulizers Nitric Oxide Delivery Units Oxygen Hoods Consumables and Accessories Disposable Masks Disposable Resuscitators Tracheostomy Tubes Nasal Cannulas Others Diagnostic Devices Spirometer Peak Flow meters Polysomnography Devices Others Monitoring Devices Pulse Oximeters Pulse Oximeter Sensors Pulse Oximeter Equipment Capnographs Gas Analyzers
By End User	Hospitals Ambulatory Care Home Care
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Fisher and Paykel Healthcare Limited, Becton, Dickinson and Company, 3M Company, ResMed Inc., GlaxoSmithKline plc, Medtronic plc, Thermo Fisher Scientific Inc., Masimo Corporation, Koninklijke Philips N.V., Hamilton Medical AG.

^*Terms and Conditions Apply